This is the formal announcement regarding the agreement with @Globalsat after the CEOs met at @Satellite2017 https://t.co/E4638a5C2F
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%